Literature DB >> 33225843

Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses.

Gabriele Rossi1, Amy Richardson1, Hali Jamaludin1, Cristy Secombe1.   

Abstract

Paraoxonase-1 (PON-1) activity is a new inflammatory and oxidative marker. Technical effects and biological factors could affect the accuracy of PON-1 activity measurement. We investigated the effects of storage at different temperatures, repeated freeze-thaw cycles, interferences from hemolytic, lipemic, and icteric samples, and seasonal effects on PON-1 activity in horses. We evaluated 2 substrates with an automated spectrophotometer. Ten equine serum samples were stored under different conditions. Although storage at room (21°C) or refrigeration (4°C) temperature induced a statistically significant decrease (p < 0.05) in PON-1 activity, this is not diagnostically relevant. PON-1 activity in frozen samples (-20°C) was stable for short-term storage; diagnostically significant (p < 0.01) fluctuations were observed after 1 mo. Four repeated freeze-thaw cycles were assessed, and all cycles affected PON-1 activity (p < 0.01); however, this was diagnostically significant only after the 4th cycle. Hemolysis induced an overestimation of PON-1 activity; lipemia and hyperbilirubinemia did not change PON-1 activity. Thirty-four horses were sampled monthly for 1 y, and PON-1 activity was higher in autumn (p < 0.05) and winter (p < 0.05) than in spring and summer.

Entities:  

Keywords:  equine; interference; paraoxonase-1; repeated freeze–thaw cycles; seasonal variability; storage

Mesh:

Substances:

Year:  2020        PMID: 33225843      PMCID: PMC7758704          DOI: 10.1177/1040638720974745

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  36 in total

1.  A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate.

Authors:  L Haagen; A Brock
Journal:  Eur J Clin Chem Clin Biochem       Date:  1992-07

2.  ASVCP quality assurance guidelines: control of preanalytical, analytical, and postanalytical factors for urinalysis, cytology, and clinical chemistry in veterinary laboratories.

Authors:  Rebekah G Gunn-Christie; Bente Flatland; Kristen R Friedrichs; Balazs Szladovits; Kendal E Harr; Kristiina Ruotsalo; Joyce S Knoll; Heather L Wamsley; Kathy P Freeman
Journal:  Vet Clin Pathol       Date:  2012-03       Impact factor: 1.180

3.  ASVCP guidelines: allowable total error guidelines for biochemistry.

Authors:  Kendal E Harr; Bente Flatland; Mary Nabity; Kathleen P Freeman
Journal:  Vet Clin Pathol       Date:  2013-12       Impact factor: 1.180

4.  Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs.

Authors:  Asta Tvarijonaviciute; Fernando Tecles; Marco Caldin; Silvia Tasca; José Cerón
Journal:  Am J Vet Res       Date:  2012-01       Impact factor: 1.156

Review 5.  The preanalytic phase in veterinary clinical pathology.

Authors:  Jean-Pierre Braun; Nathalie Bourgès-Abella; Anne Geffré; Didier Concordet; Cathy Trumel
Journal:  Vet Clin Pathol       Date:  2014-12-01       Impact factor: 1.180

6.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response.

Authors:  K R Feingold; R A Memon; A H Moser; C Grunfeld
Journal:  Atherosclerosis       Date:  1998-08       Impact factor: 5.162

8.  Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs.

Authors:  Silvia Rossi; Gabriele Rossi; Alessia Giordano; Saverio Paltrinieri
Journal:  J Vet Diagn Invest       Date:  2008-09       Impact factor: 1.279

9.  Serum paraoxonase 1 activity in dogs: preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin.

Authors:  Gabriele Rossi; Alessia Giordano; Francesca Pezzia; Mads Kjelgaard-Hansen; Saverio Paltrinieri
Journal:  Vet Clin Pathol       Date:  2013-08-14       Impact factor: 1.180

10.  Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.

Authors:  Kazuhiko Kotani; Naoki Sakane; Yoshiko Sano; Kokoro Tsuzaki; Yukiyo Matsuoka; Kahori Egawa; Makiko Yoshimura; Chika Horikawa; Yoshinori Kitagawa; Yoshinobu Kiso; Satoshi Kimura; John Schulze; Jennifer Taing; Alejandro Gugliucci
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more
  1 in total

1.  Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab.

Authors:  Elizabeth W Thompson; Biniyam G Demissei; Amanda M Smith; Priya Brahmbhatt; Jessica Wang; Amy Clark; Angela DeMichele; Vivek Narayan; Payal Shah; Lova Sun; Benedicte Lefebvre; Michael G Fradley; Joseph R Carver; W H Wilson Tang; Bonnie Ky
Journal:  JACC Basic Transl Sci       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.